Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Capital Employed (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Return on Capital Employed for 15 consecutive years, with 0.1% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 19.0% to 0.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.1% through Dec 2025, down 19.0% year-over-year, with the annual reading at 0.11% for FY2025, 14.0% down from the prior year.
  • Return on Capital Employed hit 0.1% in Q4 2025 for Ironwood Pharmaceuticals, down from 0.97% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.97% in Q3 2025 to a low of 4.91% in Q1 2024.
  • Historically, Return on Capital Employed has averaged 0.58% across 5 years, with a median of 0.08% in 2022.
  • Biggest five-year swings in Return on Capital Employed: tumbled -496bps in 2024 and later soared 509bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.04% in 2021, then increased by 13bps to 0.05% in 2022, then crashed by -8515bps to 4.27% in 2023, then surged by 107bps to 0.28% in 2024, then plummeted by -66bps to 0.1% in 2025.
  • Business Quant data shows Return on Capital Employed for IRWD at 0.1% in Q4 2025, 0.97% in Q3 2025, and 0.72% in Q2 2025.